Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
The Hallmarks of Cancer
2000 • 27,569 citations
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 • 4,416 citations
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
1999 • 2,796 citations
Mechanisms of caspase activation
2003 • 1,358 citations
Intrinsic tumour suppression
2004 • 1,267 citations
Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
2000 • 1,170 citations
Pathways of apoptotic and non-apoptotic death in tumour cells
2004 • 1,026 citations
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
2001 • 960 citations
Pro-caspase-3 Is a Major Physiologic Target of Caspase-8
1998 • 743 citations
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
2004 • 648 citations
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
2001 • 546 citations
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
2002 • 437 citations
Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway
2003 • 368 citations
Pharmacological manipulation of cell death: clinical applications in sight?
2005 • 236 citations
Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide
2001 • 178 citations
Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases
1998 • 161 citations
Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia
1998 • 148 citations
Rational Design and Real Time, In-Cell Detection of the Proapoptotic Activity of a Novel Compound Targeting Bcl-XL
2004 • 146 citations
Caspase 3 in breast cancer.
2003 • 139 citations
Direct activation of the apoptosis machinery as a mechanism to target cancer cells
2003 • 120 citations
High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.
1997 • 120 citations
Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion
1999 • 108 citations
Human Caspase-7 Activity and Regulation by Its N-terminal Peptide
2003 • 105 citations
Overexpression of caspase-3 in hepatocellular carcinomas
2004 • 104 citations
Characterization of the Interleukin-1β-Converting Enzyme/Ced-3-Family Protease, Caspase-3/CPP32, in Hodgkin's Disease
1999 • 82 citations
Targeting the FLICE Inhibitory Protein (FLIP) in Cancer Therapy
2003 • 68 citations
Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel
2004 • 65 citations
Role of Caspase 3-Dependent Bcl-2 Cleavage in Potentiation of Apoptosis by Bcl-2
2002 • 51 citations
Antisense bcl-2 treatment increases programmed cell death in non-small cell lung cancer cell lines
1999 • 43 citations
Elevated procaspase levels in human melanoma
2001 • 41 citations
Mutations in the Procaspase-3 Dimer Interface Affect the Activity of the Zymogen
2003 • 40 citations
Direct Quantitation of Poly(ADP‐Ribose) Polymerase (PARP) Activity as a Means to Distinguish Necrotic and Apoptotic Death in Cell and Tissue Samples
2004 • 32 citations
Protein hijacking
2004 • 10 citations